A-A-51574A
1 July 1987
SUPERSEDING
A-A-0051574
14 July 1986
COMMERCIAL ITEM DESCRIPTION
AMOXICILLIN AND POTASSIUM CLAVULANATE TABLETS
The General Services Administration has authorized the use of this Commercial Item Description.
Salient Characteristics:
Shall be Amoxicillin and Potassium Clavulanate Tablets.
Shall be in accordance with the requirements of the FDA.
Materials used in the manufacture shall be of pharmaceutical grade.
For Type 1, shall contain the equivalent of 250 mg of Amoxicillin and 125 mg of Clavulanic Acid per tablet, within the applicable assay limits.
For Type 2, shall contain the equivalent of 500 mg of Amoxicillin and 125 mg of Clavulanic Acid per tablet, within the applicable assay limits.
Workmanship. The tablets shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Bottle (BT). One bottle containing 30 tablets, as specified, constitutes one unit. Bottle shall be supplied with a child-resistant safety closure and shall have a minimum height of 51 mm base to shoulder.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producers’ own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business